Home/Filings/4/0001178913-10-000281
4//SEC Filing

MORI TOSHIO 4

Accession 0001178913-10-000281

CIK 0000793279other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:33 PM ET

Size

20.2 KB

Accession

0001178913-10-000281

Insider Transaction Report

Form 4
Period: 2010-01-05
MORI TOSHIO
V.P., Japanese Operations
Transactions
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2010-01-055,1580 total
    Exercise: $11.98Exp: 2014-01-29Common Stock, $0.01 par value per share (15,000 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2010-01-0520,0000 total
    Exercise: $4.67Exp: 2013-04-29Common Stock, $0.01 par value per share (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (right to buy)

    2010-01-059,8420 total
    Exercise: $11.98Exp: 2014-01-29Common Stock, $0.01 par value per share (15,000 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights (right to buy)

    2010-01-0560,0000 total
    Exercise: $4.29Exp: 2018-01-25Common Stock, $0.01 par value per share (60,000 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights (right to buy)

    2010-01-0530,0000 total
    Exercise: $15.33Exp: 2016-01-30Common Stock, $0.01 par value per share (30,000 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights (right to buy)

    2010-01-0532,4910 total
    Exercise: $0.41Exp: 2019-01-19Common Stock, $0.01 par value per share (32,491 underlying)
Footnotes (7)
  • [F1]The stock-settled stock appreciation rights, which were exercisable in two equal installments beginning on January 19, 2010, were vested in full and assumed by Syneron Medical Ltd. ("Syneron") pursuant to a merger agreement between the Issuer and Syneron Medical Ltd. and replaced with stock-settled stock appreciation rights to purchase 9,458 ordinary shares of Syneron at an exercise price of $1.41 per share.
  • [F2]The stock-settled stock appreciation rights, which were exercisable in four equal annual installments beginning on January 30, 2007, were cancelled by Candela.
  • [F3]The incentive stock options, which were exercisable in four equal installments beginning on April 29, 2004, were cancelled by Candela.
  • [F4]The incentive stock options, which were exercisable in four annual installments beginning on January 29, 2005, were cancelled by Candela.
  • [F5]The non-qualified stock options, which were exercisable in four annual installments beginning on January 29, 2005, were cancelled by Candela.
  • [F6]The stock-settled stock appreciation rights, which were exercisable in four equal annual installments beginning on January 25, 2009, were cancelled by Candela.
  • [F7]The stock-settled stock appreciation rights, which were exercisable in four equal installments beginning on April 3, 2008, were cancelled by Candela.

Issuer

CANDELA CORP /DE/

CIK 0000793279

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001233074

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:33 PM ET
Size
20.2 KB